Estrogen modulation of fibroblast function in the pressure overloaded heart

雌激素对压力超负荷心脏成纤维细胞功能的调节

基本信息

项目摘要

DESCRIPTION (provided by applicant): Increased cardiovascular load results in an adaptive process including myocardial hypertrophy and fibrosis. In pathological situations, this adaptive response can progress into myocardial dysfunction and eventually heart failure. Premenopausal females are relatively protected from cardiovascular diseases including loadinduced hypertrophy and heart failure. Recent studies have illustrated that the ovarian hormone, 17 betaestradiol plays an essential role in mediating gender-specific cardioprotection; however, many questions remain regarding the molecular and cellular mechanisms of these effects. Interstitial fibroblasts are critical to myocardial function as these cells produce and remodel the myocardial extracellular matrix. Alterations in the organization and accumulation of the extracellular matrix can deleteriously affect myocardial function and are thought to be important determinants in the progression to heart failure. Little is known regarding the effects of gender and ovarian hormones in the regulation of fibroblast gene expression and function. The proposed studies will determine the effects of gender and 17 beta- estradiol on myocardial fibrosis. These studies will test the over-riding hypothesis that gender-specific differences in the progression of cardiac fibrosis are due to the direct attenuation of the fibroblast response to pro-fibrotic biochemical factors and mechanical forces by 17 beta-estradiol. Specific Aims designed to test this hypothesis include: 1) to determine the effects of gender and 17 beta- estradiol on fibroblast behavior and gene expression in the pressure overloaded myocardium, 2) to determine the mechanisms whereby 17 beta- estradiol represses the pro-fibrotic response of cardiac fibroblasts to angiotensin II and 3) to elucidate the mechanisms through which 17 beta- estradiol attenuates the response of cardiac fibroblasts to mechanical stretch. These studies will utilize whole animal and isolated cell models to assay the effects of gender and 17 beta- estradiol on fibroblast gene expression and behavior (contractility, proliferation and adhesion). The proposed studies will conclusively determine the effects of gender and ovarian hormones on myocardial fibrosis and will begin to elucidate the molecular mechanisms of these effects. These studies will be important towards understanding the cardioprotective mechanisms of gender in heart diseases involving the myocardial interstitium.
描述(由申请人提供):心血管负荷增加导致适应性过程,包括心肌肥大和纤维化。在病理情况下,这种适应性反应可能进展为心肌功能障碍并最终导致心力衰竭。绝经前女性相对免受心血管疾病的影响,包括负荷引起的肥大和心力衰竭。最近的研究表明,卵巢激素 17 β-雌二醇在介导性别特异性心脏保护方面发挥着重要作用。然而,关于这些效应的分子和细胞机制仍然存在许多问题。间质成纤维细胞对心肌功能至关重要,因为这些细胞产生并重塑心肌细胞外基质。细胞外基质的组织和积累的改变会对心肌功能产生有害影响,并被认为是心力衰竭进展的重要决定因素。关于性别和卵巢激素在成纤维细胞基因表达和功能调节中的影响知之甚少。拟议的研究将确定性别和 17 β-雌二醇对心肌纤维化的影响。这些研究将检验最重要的假设,即心脏纤维化进展中的性别特异性差异是由于成纤维细胞对促纤维化生化因素和 17 β-雌二醇机械力的反应直接减弱所致。旨在检验这一假设的具体目的包括:1) 确定性别和 17 β-雌二醇对压力超负荷心肌中成纤维细胞行为和基因表达的影响,2) 确定 17 β-雌二醇抑制心脏成纤维细胞对血管紧张素 II 的促纤维化反应的机制,以及 3) 阐明 17 β-雌二醇的机制 减弱心脏成纤维细胞对机械拉伸的反应。这些研究将利用整个动物和分离的细胞模型来测定性别和 17 β-雌二醇对成纤维细胞基因表达和行为(收缩性、增殖和粘附)的影响。拟议的研究将最终确定性别和卵巢激素对心肌纤维化的影响,并将开始阐明这些影响的分子机制。这些研究对于了解涉及心肌间质的心脏病中性别的心脏保护机制具有重要意义。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effects of interleukin-33 on cardiac fibroblast gene expression and activity.
  • DOI:
    10.1016/j.cyto.2012.02.008
  • 发表时间:
    2012-06
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Zhu, Jinyu;Carver, Wayne
  • 通讯作者:
    Carver, Wayne
Temporal alterations in cardiac fibroblast function following induction of pressure overload.
  • DOI:
    10.1007/s00441-010-0943-2
  • 发表时间:
    2010-04
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Stewart, James A., Jr.;Massey, Erin P.;Fix, Charity;Zhu, Jinyu;Goldsmith, Edie C.;Carver, Wayne
  • 通讯作者:
    Carver, Wayne
Activation of cardiac fibroblasts by ethanol is blocked by TGF-β inhibition.
Effects of interleukin-18 on cardiac fibroblast function and gene expression.
白介素18对心脏成纤维细胞功能和基因表达的影响。
  • DOI:
    10.1016/j.cyto.2010.10.002
  • 发表时间:
    2011-01
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Fix, Charity;Bingham, Kellie;Carver, Wayne
  • 通讯作者:
    Carver, Wayne
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WAYNE E CARVER其他文献

WAYNE E CARVER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WAYNE E CARVER', 18)}}的其他基金

Developing natural compound emodin as a therapy for alcoholic cardiomyopathy
开发天然化合物大黄素治疗酒精性心肌病
  • 批准号:
    10597858
  • 财政年份:
    2023
  • 资助金额:
    $ 39.66万
  • 项目类别:
INBRE: USC: ENHANCEMENT OF BIOENGINEERING PROGRAM AT USC
INBRE:南加州大学:南加州大学生物工程项目的加强
  • 批准号:
    8360737
  • 财政年份:
    2011
  • 资助金额:
    $ 39.66万
  • 项目类别:
INBRE: USC: ENHANCEMENT OF BIOENGINEERING PROGRAM AT USC
INBRE:南加州大学:南加州大学生物工程项目的加强
  • 批准号:
    8168147
  • 财政年份:
    2010
  • 资助金额:
    $ 39.66万
  • 项目类别:
INBRE: USC: ENHANCEMENT OF BIOENGINEERING PROGRAM AT USC
INBRE:南加州大学:南加州大学生物工程项目的加强
  • 批准号:
    7959583
  • 财政年份:
    2009
  • 资助金额:
    $ 39.66万
  • 项目类别:
INBRE: USC: ENHANCEMENT OF BIOENGINEERING PROGRAM AT USC
INBRE:南加州大学:南加州大学生物工程项目的加强
  • 批准号:
    7720392
  • 财政年份:
    2008
  • 资助金额:
    $ 39.66万
  • 项目类别:
Estrogen modulation of fibroblast function in the pressure overloaded heart
雌激素对压力超负荷心脏成纤维细胞功能的调节
  • 批准号:
    7799997
  • 财政年份:
    2007
  • 资助金额:
    $ 39.66万
  • 项目类别:
Estrogen modulation of fibroblast function in the pressure overloaded heart
雌激素对压力超负荷心脏成纤维细胞功能的调节
  • 批准号:
    7262167
  • 财政年份:
    2007
  • 资助金额:
    $ 39.66万
  • 项目类别:
Estrogen modulation of fibroblast function in the pressure overloaded heart
雌激素对压力超负荷心脏成纤维细胞功能的调节
  • 批准号:
    7406096
  • 财政年份:
    2007
  • 资助金额:
    $ 39.66万
  • 项目类别:
Estrogen modulation of fibroblast function in the pressure overloaded heart
雌激素对压力超负荷心脏成纤维细胞功能的调节
  • 批准号:
    7587251
  • 财政年份:
    2007
  • 资助金额:
    $ 39.66万
  • 项目类别:
Role of ADAMs in Heart Myocyte Development
ADAM 在心肌细胞发育中的作用
  • 批准号:
    6537862
  • 财政年份:
    2001
  • 资助金额:
    $ 39.66万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39.66万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39.66万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.66万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.66万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39.66万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.66万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39.66万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39.66万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39.66万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.66万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了